Close Menu

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics today announced it has again received ISO 13485:2003 certification for the design, manufacture, and distribution of instruments, software, reagents, and test kits for gene expression analysis.

The certification covers design, development, manufacture, sale, and distribution of the firm's quantitative nuclease-protection assay (qNPA) gene expression analysis products and services.

Tucson, Arizona-based HTG first received ISO 13485:2003 certification in 2012.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.